Beijing Shuanghe Pharmaceutical Co., Ltd. Shuanghe products.

1. Large infusion: It has six strategic production bases, namely Beijing Industrial Park, Anhui, Binhu, Jianli, Jingxi and Huai 'an, with an annual production capacity of 600 million bottles (bags) and an annual output of 448.48 million bottles, accounting for/kloc-0.2% of China's large infusion market.

Production of nearly 90 varieties, including parenteral nutrient solution, electrolyte balance solution; Antibacterial, cardiovascular and other therapeutic liquids; Crystal and colloidal plasma substitutes; Dialysis solution. The company deeply promotes the concept of "double-hanging infusion is safe", and its sales network is all over the country, and its market share is in a leading position in the same industry in China. Beijing's market share is as high as 65%, and Lifosun and Aofosun infusion account for about 65% of the domestic market share.

Generic name: hydroxyethyl starch (200/0.5) sodium chloride injection.

Trade name: Yingyuan

Function description: This product is a plasma expander.

1. Treat and prevent hypovolemia or shock related to operation, hemorrhagic shock, trauma, traumatic shock, infection, septic shock, burns and burn shock.

2. Reduce the demand for blood supply during surgery and save blood: for example, acute normovolemic hemodilution (ANH).

3. Therapeutic hemodilution. Gatifloxacin and sodium chloride injection.

Product model

Function introduction is used to treat infectious diseases caused by sensitive strains.

Product name Lifosun infusion

Product model

Function introduction is suitable for all kinds of mild and moderate infections caused by sensitive bacteria: respiratory, digestive, urinary, reproductive, skin and soft tissue infections; Our fist products have been selling well for more than 30 years, with complete independent intellectual property rights, and won the title of famous brand products in Beijing many times. After decades of market cultivation and development, it has more than 4.3 million audiences and achieved 100% market coverage in major pharmacies across the country. The sales volume of No.0 increased from 89 1000 in 1997 to 730 million in 2006, and the sales volume increased nearly 80 times in ten years. From the listing of 1986 to 2006, the cumulative production and sales reached 3 billion pieces, with an annual output of 800 million pieces. Known as "the first in China", it has created an annual output value of nearly 500 million yuan. No.0 has maintained a sustained growth momentum, becoming the leading brand in the antihypertensive drug market, and has obtained the opportunity to cooperate with the national tenth five-year plan project.

Product name No.0 (Compound reserpine and triamterene tablets)

Function description: It is used to treat mild to moderate hypertension, and severe hypertension needs to be combined with other antihypertensive drugs.

Introduction of product name and function Sodium nitroprusside for injection can be used for emergency hypotension in hypertensive emergencies, such as hypertensive crisis, hypertensive encephalopathy, malignant hypertension and paroxysmal hypertension before and after pheochromocytoma operation, and can also be used for controlled hypotension during surgical anesthesia.

Can be used for treating acute heart failure, including acute pulmonary edema. When the valve (mitral valve or aortic valve) is not completely closed, it is also used for acute myocardial infarction or acute heart failure.

Shuxuening injection

Product name Shuxuening injection product model Brief introduction of injection function dilates blood vessels and improves microcirculation. Used for ischemic cardiovascular and cerebrovascular diseases, coronary heart disease, angina pectoris, cerebral embolism, cerebral vasospasm, etc.

Cooperation, the introduction of oral hypoglycemic drugs developed by Boehringer Ingelheim company in Germany, filled the gap in the field of endocrine drugs. Tang Shiping entered the domestic market as a generic drug, and explored the domestic market by leasing prescriptions, leasing product brands and self-production. The sales scale increased from the initial 6.5438+million yuan to more than 200 million yuan in 2006, an increase of nearly 20 times in ten years. Tang Shiping won the title of Beijing famous brand product for two years in a row, and was rated as "the first choice brand for consumers' satisfaction with diabetes drugs in China" by People's Daily and other media. According to the data analysis of IMS market research company, Shuanghe hypoglycemic products ranked fourth in China market and fifth in market share in 2005.

The company has continuously increased the research and development and introduction of new products in the field of endocrine, and introduced relay varieties such as pioglitazone hydrochloride and metformin sustained-release capsules, further enriching the product structure in the field of endocrine therapy.

Product name: Tang Shiping

Function description: drugs for treating type 2 diabetes; Only 5% is excreted by the kidney, which can be used by patients with mild to moderate renal insufficiency. Product name Common name: piperacillin sodium and sulbactam sodium for injection 4: 1.

Product name: Yijun

Function description: Broad-spectrum antibacterial agent covers most pathogenic bacteria such as Gram-positive bacteria, Gram-negative bacteria and anaerobic bacteria, and has good antibacterial effect on Pseudomonas aeruginosa, Acinetobacter, Escherichia coli producing ESBL and Klebsiella pneumoniae.

Product name: Booker

Function description: drugs for preventing and treating type 2 diabetes; Once a day, convenient to take; Reduce diabetic complications in an all-round way.